| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/16/1999 | US5871748 Administering to the subject a vaccine complex comprising a live vaccine virus and antibodies bound to said live vaccine virus |
| 02/16/1999 | US5871746 For immunizing against pathogenic agents such as viruses orparasites; one or more chains derived from fatty acids or modified steroid groups |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871744 Method for generating birnavirus from synthetic RNA transcripts |
| 02/16/1999 | US5871742 Dna codes for polypeptides with amino acid sequences |
| 02/16/1999 | US5871733 Viricides with intracellular adhesion molecule proteins for binding rhinovirus |
| 02/16/1999 | US5871732 Dna sequences and genetic engineering for aids |
| 02/16/1999 | CA2083386C Phosphorous prodrugs |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/11/1999 | WO1999006577A2 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 02/11/1999 | WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | WO1999006430A1 Alatrofloxacin parenteral compositions |
| 02/11/1999 | WO1999006424A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006422A2 Base analogues |
| 02/11/1999 | WO1999006410A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | WO1999006367A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006365A1 Mercaptoacylamino acids as metallo-beta-lactamase inhibitors |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006055A1 Polynucleotide compositions |
| 02/11/1999 | WO1999006047A1 Use of rifamycin derivative for treating mastitis in a domestic animal |
| 02/11/1999 | WO1999006044A1 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 02/11/1999 | WO1999006043A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006037A1 Novel diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus |
| 02/11/1999 | WO1999006024A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/11/1999 | WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/11/1999 | DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide |
| 02/11/1999 | CA2303429A1 Novel diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298682A1 Mercaptoacylamino acids as metallo-beta-lactamase inhibitors |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 02/11/1999 | CA2298061A1 Polynucleotide compositions |
| 02/11/1999 | CA2297988A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | CA2297776A1 Base analogues |
| 02/11/1999 | CA2297757A1 Caspases and apoptosis |
| 02/11/1999 | CA2297076A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 02/11/1999 | CA2297012A1 Use of rifamycin derivative for treating mastitis in a domestic animal |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |
| 02/11/1999 | CA2294032A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0895999A1 C-4" substituted macrolide antibiotics |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895534A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM |
| 02/10/1999 | CN1207769A Tissue-specific and target RNA-specific ribozymes |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207741A Synthetic metal-substituted bacteriochlorophyll derivs. and use thereof |
| 02/10/1999 | CN1207295A Medical preparation for feet |
| 02/10/1999 | CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment |
| 02/09/1999 | US5869711 Ceramide compounds, process for their preparation and use |
| 02/09/1999 | US5869670 7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
| 02/09/1999 | US5869666 4',6'-cyclopropane-fused carboxylic nucleoside analogs in which the oxygen in the ribose ring is substituted for carbon; antimetabolites; locking dna in solution to examine dna-protein, dna-rna and dna-dna interactions |
| 02/09/1999 | US5869659 Microbiocides |
| 02/09/1999 | US5869624 HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 02/09/1999 | US5869522 Solvent extraction; plant extracts; trimerization of 2,3-deoxy-1,4-naphthoquinone |
| 02/09/1999 | US5869512 Azole compounds with antimycotic activity for human and veterinary use |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869477 β-methylcarbapenem derivatives, process for the preparation thereof and pharmaceutical composition comprising same |
| 02/09/1999 | US5869467 Viricides |
| 02/09/1999 | US5869457 Modified proteins and their use for controlling viral infections |
| 02/09/1999 | US5869453 Cytotoxic T-cell epitopes |
| 02/09/1999 | US5869449 Improved antibacterial activity against some clinical isolates of staphylococci somewhat resistant to teicoplanin. |
| 02/09/1999 | US5869447 Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 02/09/1999 | US5869324 Chiral resolution by contacting mixture with enzyme and acylating agent, separating esterified calanolide a |
| 02/09/1999 | US5869313 Dna fragments coding for envelope and regulatory proteins of hiv-1 strains common to united states; for vaccines and detection in blood samples |
| 02/09/1999 | US5869312 Recombinant swinepox virus |
| 02/09/1999 | US5869302 Analog of haemophilus hin47 with reduced protease activity |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869079 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 02/09/1999 | US5869066 Vaccine containing a campylobacter bacterium having an enhanced antigenic property |
| 02/09/1999 | US5869065 Haemophilus influenzae; otitis media; sinusitis; bronchitis; dna sequences; amino acid sequences |
| 02/09/1999 | US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
| 02/09/1999 | US5869038 Biological control of fungal post harvest diseases with bacteria |
| 02/09/1999 | US5869036 Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |